Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement
使用 Janus 激酶抑制剂治疗免疫介导的炎症性疾病需要考虑的要点:共识声明
期刊:Annals of the Rheumatic Diseases
影响因子:20.6
doi:10.1136/annrheumdis-2020-218398
Nash, Peter; Kerschbaumer, Andreas; Dörner, Thomas; Dougados, Maxime; Fleischmann, Roy M; Geissler, Klaus; McInnes, Iain; Pope, Janet E; van der Heijde, Désirée; Stoffer-Marx, Michaela; Takeuchi, Tsutomu; Trauner, Michael; Winthrop, Kevin L; de Wit, Maarten; Aletaha, Daniel; Baraliakos, Xenofon; Boehncke, Wolf-Henning; Emery, Paul; Isaacs, John D; Kremer, Joel; Lee, Eun Bong; Maksymowych, Walter P; Voshaar, Marieke; Tam, Lai-Shan; Tanaka, Yoshiya; van den Bosch, Filip; Westhovens, René; Xavier, Ricardo; Smolen, Josef S